The Leadership Summit will bring senior pharma executives together to discuss supply chain resilience, medicine security, and manufacturing capacity amid growing geopolitical fragmentation.
|Articles|April 4, 2018
- Pharmaceutical Technology\'s In the Lab eNewsletter-05-02-2018
- Volume 13
- Issue 5
Q&A Podcast Series: Measuring Elemental Impurities in Pharmaceuticals with Rob Thomas
Rob Thomas, principal consultant at Scientific Solutions, discusses the impetus behind his new book, Measuring Elemental Impurities in Pharmaceuticals: A Practical Guide, published on Feb. 2, 2018.
Advertisement
In this three-part podcast series, Rob Thomas, principal consultant at Scientific Solutions, discusses the impetus behind his new book, Measuring Elemental Impurities in Pharmaceuticals: A Practical Guide, published on Feb. 2, 2018. The book provides a training tool for novices and inexperienced users of plasma spectrochemistry as well as for supervisors and senior management who want to better understand the analytical issues.
Articles in this issue
over 8 years ago
Automated Microencapsulation Systemover 8 years ago
Complete Protein Particle Characterization from Multiple Viewsover 8 years ago
Selexis SA Invests in New Lab Equipment and Personnelover 8 years ago
Nelson Labs Expands Lab Operations and Testing Capabilitiesover 8 years ago
Thermo Fisher Showcases New Equipment at Analytica 2018over 8 years ago
AGC Biologics to Add New Facilities at Headquartersover 8 years ago
BioSpectra Expands Manufacturing Capacity and Lab Servicesover 8 years ago
PCI Pharma Expands Analytical CapabilitiesAdvertisement
Related to this article
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Can AI Agents Satisfy CGMP Documentation Requirements?
2
Spray Drying Capacity Signals Faster Paths for Poorly Soluble Drugs
3
Introducing the "PharmTech AI Pulse Check" Expert Video Series
4
Two Audit Case Studies Reveal the Cost of Incomplete Corrective Actions
5